SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2005

                            Commission File #2-89616

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.


             (Exact name of registrant as specified in its charter)

                                     MONTANA

         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

               11919 Sunray Avenue, Suite B, Baton Rouge, LA 70816
               (Address of principal executive offices)(Zip Code)

                                  222-292-5139
                (Registrant's telephone no., including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [X] No [ ]

The number of shares outstanding of the Company's common stock as of June 30,
2005 is shown below:

Title of Class Number of Shares Outstanding Common Stock, par value $.001 per
share 44,544,223.

Documents Incorporated by Reference: None


<PAGE>
<TABLE>
<CAPTION>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB

                                Table of Contents


<S>                                                            <C>
PART  I  -  Financial Information
Item  1  -  Financial Statements
Item  2  -  Management's Discussion and Analysis of Financial
            Condition and Operations
Item  3  -  Controls and Procedures
Item  4  -  Submission of Matters to a vote of security
            Holders
Item  5  -  Exhibits & Reports on Form 8-K

PART II  -  OTHER INFORMATION

Item  2  -  Changes in Securities and Use of Proceeds
Item  6  -  Exhibits and Reports on Form 8-K

SIGNATURES
</TABLE>


<PAGE>
                         PART I - FINANCIAL INFORMATION



ITEM 1. FINANCIAL STATEMENTS

AS USED HEREIN, THE TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT
INC. UNLESS OTHERWISE INDICATED. CONSOLIDATED UNAUDITED INTERIM FINANCIAL
STATEMENTS INCLUDING A BALANCE SHEET FOR THE COMPANY AS OF THE QUARTER ENDED
JUNE 30, 2005, STATEMENT OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE
INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF
THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN
BY THIS REFERENCE.


                                        2
<PAGE>
<TABLE>
<CAPTION>
                     CONSOLIDATED MINERALS MANAGEMENT, INC.
                            (A MONTANA CORPORATION)
                           CONSOLIDATED BALANCE SHEET
                                  (UNAUDITED)


                                     ASSETS
                                     ------
Current Assets                                               June 30, 2005     December 31, 2004
--------------                                             ------------------  ------------------
<S>                                                        <C>                 <C>
Cash                                                       $             420   $            9,455
                                                           ------------------  ------------------

      Total Current Assets                                               420                9,455
                                                           ------------------  ------------------

Other Assets
Oil & Gas Properties - Non Producing                       $          60,000               60,000
Notes Receivable                                                   2,506,000            2,506,000
Investment in Intercontinental Fuels, LLC                          1,600,000            1,600,000
                                                           ------------------  ------------------
      Total Other Assets                                           4,166,000            4,166,000
                                                           ------------------  ------------------

            Total Assets                                   $       4,166,420   $        4,175,455
                                                           ==================  ==================

                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                 ----------------------------------------------
Current Liabilities

Accounts payable & accrued expenses                                  330,536              370,066
Debentures payable                                                   500,000              350,000
                                                           ------------------  ------------------
      Total current  iabilities                                      830,536              720,066

Note Payable Dr. Zehr                                              2,000,000            2,000,000
Debentures Payable                                                   600,000              600,000
                                                           ------------------  ------------------

    Total long term liabilities                                    2,600,000            2,600,000
                                                           ------------------  ------------------


        Total Liabilities                                  $       3,430,536   $        3,320,066

Commitments and Contingencies:

Stockholders' Equity
        Preferred Stock
        20,000,000 authorized shares, par value $.001
        no shares issued and outstanding

Common Stock                                               $          44,544   $           44,544
0.001 par value, 50,000,000 shares authorized
44,544,223 shares issued and outstanding as of
June 30, 2005 and 44,544,223 shares issued
and outstanding as of December 31, 2004

Additional Paid-in-Capital                                         4,332,172            4,332,172
Retained Earnings (Deficit)                                       (3,640,832)          (3,521,327)
                                                           ------------------  ------------------

    Total Stockholders' Equity (Deficit)                             735,884              855,389
                                                           ------------------  ------------------

    Total Liabilities and Stockholders' Equity (Deficit)   $       4,166,420   $        4,175,455
                                                           ==================  ==================
</TABLE>


                                        3
<PAGE>
<TABLE>
<CAPTION>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
                            (A MONTANA CORPORATION)
                      CONSOLIDATED STATEMENT OF OPERATIONS
                                  (UNAUDITED)


                                     Three Months Ended June 30,      Six Months Ended June 30,
                                    ------------------------------  ----------------------------
                                         2005            2004           2005            2004
                                    --------------  --------------  -------------  -------------
<S>                                 <C>             <C>             <C>            <C>
Revenues                            $               $           -   $          -   $           -
--------
Operating Expenses
    Personnel Costs                             -          24,000                         43,000
    Consulting                             57,000          44,600        114,000          85,684
    Legal and Professional                      -             428              -           1,578
    Other Expenses                          1,965           9,310          5,505          17,996
                                    --------------  --------------  -------------  -------------

    Total Operating Expenses        $      58,965   $      78,338   $    119,505   $     148,258

Income (Loss) from Operations             (58,965)        (78,338)      (119,505)       (148,258)

Other Income (Expenses)
      Interest Expense                          0               0              0         (20,342)
                                    --------------  --------------  -------------  -------------

Income (Loss) before Income Taxes   $     (58,965)  $     (78,338)  $   (119,505)       (168,600)

Income Tax Expense                              0               0              0               0
                                    --------------  --------------  -------------  -------------
Net Income (Loss)                   $     (58,965)  $     (78,338)  $   (119,505)  $    (168,600)
                                    ==============  ==============  =============  =============

Net Income (Loss) per Share         $      (.0013)  $      (.0017)  $     (.0027)  $      (.0038)
                                    ==============  ==============  =============  =============
</TABLE>


                                        4
<PAGE>
<TABLE>
<CAPTION>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC
                             (A MONTANA CORPORATION)
                         CONSOLIDATED STATEMENT OF CASH
                                   (UNAUDITED)
                            SIX MONTHS ENDED JUNE 30


Cash Flows from Operating Activities:                      2005        2004
-------------------------------------                    ---------  ---------
<S>                                                      <C>        <C>
  Net Income (Loss)                                      $(58,965)  $(78,338))
  Adjustments to Reconcile Net Income (Loss) to
      Net Cash Provided by Operating Activities:
        Depreciation and Amortization
        (Increase) Decrease in Investments
        (Increase) Decrease in Receivable
        (Decrease) Increase in Accounts Payable                 0           0
        (Increase) Decrease in Interest                         0           0
        (Increase) Decrease in Accrued                    (58,982)    (78,002)
                                                         ---------  ---------

      Net Cash Provided (Used) by Operating Activities   $     17   $    (336)
                                                         ---------  ---------

Cash Flows from Investing Activities:

  Assets Disposed

      Net Cash Provided (Used) by Investing Activities   $          $
                                                         ---------  ---------


Cash Flows from Financing Activities:
    Increase in Long-Term Debt
    Increase in Short-Term Debt
    Increase in Paid in capital
    Common Stock
                                                         ---------  ---------

      Net Cash Provided (Used) by Financing Activities   $      0   $       0
                                                         ---------  ---------

Net Increase (Decrease) in Cash                                17        (336)

Cash, Beginning of period                                     403         739
                                                         ---------  ---------

Cash, End of period                                      $    420   $     403

                                                         =========  =========
Supplemental Disclosure of Cash Flow Information
    Cash Paid During the Period for:                     $      0   $       0
                                                         =========  =========
Interest

      Income Taxes                                       $      0   $       0
                                                         =========  =========
</TABLE>

                                        5
<PAGE>
NOTE 1 - BASIS OF PRESENTATION
------------------------------

GENERAL
-------

The consolidated unaudited interim financial statements of the Company as of
June 30, 2005 and for the three months and six months ended June 30, 2005,
included herein have been prepared in accordance with the instructions for Form
10QSB under the Securities Exchange Act of 1934, as amended, and Article 10 of
Regulation S-X under the Securities Act of 1933, as amended. The December 31,
2004 Consolidated Balance Sheet was derived from audited financial statements,
but does not include all disclosures required by generally accepted accounting
principles. Certain information and note disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and regulations
relating to interim consolidated financial statements.

In the opinion of management, the accompanying consolidated unaudited interim
financial statements reflect all adjustments, consisting only of normal
recurring adjustments, necessary to present fairly the financial position of the
Company at June 30, 2005, and the results of their operations for the three and
six months ended June 30, 2005 and June 30, 2004, and their cash flows for the
three and six months ended June 30, 2005 and June 30, 2004.

The results of operations for such periods are not necessarily indicative of
results expected for the full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements as of December 31, 2004 and related notes included in the Company's
Form 10-KSB filed with the Securities and Exchange Commission.

                                  ORGANIZATION

Consolidated Medical Management, Inc. (CMMI), was incorporated under the laws of
the State of Montana on August 13, 1981 under the name Golden Maple Mining and
Leaching Company, Inc. On May 23, 1998, we changed our name to Consolidated
Medical Management, Inc. In August 2001, the Company decided to refocus on the
oil and gas industry and are currently doing business as Consolidated Minerals
Management, Inc. CMMI moved its corporate office in July 2003 to Baton Rouge,
LA.


                                        6
<PAGE>
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
---------------------------------------------------

ACCOUNTING METHOD
-----------------

Accounting policies of the Company conform to the generally accepted accounting
principles and reflect practices appropriate to the industry in which it
operates. The significant policies are summarized below.


CASH FLOWS AND CONCENTRATION OF CREDIT RISK
-------------------------------------------

Cash consists principally of demand deposits at commercial banks. These
balances, as reflected in the bank's records, are insured by the Federal Deposit
Insurance Corporation up to $100,000. At December 31, 2004 and June 30, 2005,
the Company's deposits did not exceed the insured limits.

EARNINGS PER COMMON SHARE
-------------------------

The Company adopted Financial Accounting Standards (SFAS) No. 128, "Earnings Per
Share," which simplifies the computation of earnings per share requiring the
restatement of all prior periods.

Basic earnings per share are computed on the basis of the weighted average
number of common shares outstanding during each year.

Diluted earnings per share are computed on the basis of the weighted average
number of common shares and dilutive securities outstanding. Dilutive securities
having an anti-dilutive effect on diluted earnings per share are excluded from
the calculation. The Company does not have any dilutive securities as of June
30, 2005.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES
------------------------------------------

The preparation of financial statements requires management to make estimates
and assumptions that affect reported earnings.  The estimates and assumptions
are evaluated on an on-going basis and are based on historical experience and
other factors that management believes are reasonable.  Estimates and
assumptions include, but are not limited to commitments and contingencies.

The Company believes that the following represent the areas where more critical
estimates and assumptions are used in the preparation of the financial
statements:

LONG-LIVED ASSETS IMPAIRMENTS:  The Company records impairments when the
carrying amounts of long-lived assets are determined not to be recoverable.
Impairment is assessed and measured by an estimate of future cash flows expected
to result from the use of the asset and its eventual disposition.  Changes in
market conditions can impact estimated future cash flows from use of these
assets and impairment charges may be required should such changes occur.


NOTE 3 - CONVERTIBLE DEBENTURES AND NOTES PAYABLE
-------------------------------------------------

The Company issued a $350,000 debenture on April 15, 2003 which is unsecured and
includes interest at 5% per annum. The debenture matured on October 15, 2003 and
is in default.

The Company issued Convertible Debenture No. 300 on April 15, 2003.  The
debenture bears interest at the rate of 5% per annum and matures on April 15,
2006.  The debenture is convertible after April 15, 2004 into $2,000,000 of
common stock at a cost per share of seventy per cent of the average bid price
for the stock for the immediate twenty (20) days before exercise.

Additionally, the Company issued notes to Dr. David Zehr in the amounts of
$600,000 and $150,000 on July 1, 2003 and July 6, 2003, respectively. The notes
were issued in conjunction with the acquisition of the fuel distribution
facility.


NOTE 4 - COMMON AND PREFERRED STOCK
-----------------------------------

COMMON STOCK
------------

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of December 31, 2004 and June 30, 2005, the Company had 44,544,223
and 44,544,223 shares issued and outstanding, respectively.

PREFERRED STOCK
---------------

In 1998, the Company amended its articles to authorize Preferred Stock. There
are 20,000,000 shares authorized with a par value of $0.001. The shares are
non-voting and non-redeemable by the Company. The Company further designated two
series of its Preferred Stock: "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock," with the number of authorized shares set at 1,079,957 shares. As of June
30, 2005 and December 31, 2004 there are no shares issued and outstanding.


                                        7
<PAGE>
DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to the holders of any common stock, shall be entitled to receive, as and when
declared payable by the Board of Directors from funds legally available for the
payment thereof, dividends in lawful money of the United States of America at
the rate per annum fixed and determined as herein authorized for the shares of
such series, but no more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on the day prior to each such respective dividend payment date. In no event
shall the holders of either series receive dividends of more than one percent
(1%) in any fiscal year. Each share of both series shall rank on parity with
each other share of preferred stock, irrespective of series, with respect to
dividends at the respective fixed or maximum rates for such series.

CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common stock of the Company at any time. Said shares shall be convertible at a
rate equal to three (3) shares of common stock of the Company for each one (1)
share of Series "A" or $12.50 Preferred Stock. The Series "A" $12.50 Preferred
Stock shall be convertible, in whole or in part, at any time after the common
stock of the Company shall maintain an average bid price per share of at least
$12.50 for ten (10) consecutive trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock. The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for ten
(10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus
the amount of any dividends declared and unpaid thereon.


NOTE 5 - COMMITMENT AND CONTINGENCIES
-------------------------------------

The company has not recognized any commitments or contingencies at this time.

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenues sufficient to cover
its operating costs that raises substantial doubt about its ability to continue
as a going concern. The stockholders/officers and or directors have committed to
advancing operating costs of the Company interest free.


                                        8
<PAGE>
ITEM 2. MANAGEMENT DISCUSSION AND ANAYLSIS OF FINACIAL CONDITION OR PLAN OF
OPERATIONS.

The following discussion should be read in conjunction with our unaudited
consolidated interim financial statements and related notes thereto included in
this quarterly report and in our audited consolidated financial statements and
Management's Discussion and Analysis of Financial Condition and Results of
Operations (MD&A") contained in our Form 10-KSB for the year ended December 31,
2004. Certain statements in the following MD&A are forward looking statements.
Words such as "expects", "anticipates", "estimates" and similar expressions are
intended to identify forward-looking statements. Such statements are subject to
risks and uncertainties that could cause actual results to differ materially
from those projected.

GENERAL

Consolidated Medical Management, Inc. ("CMMI"), was incorporated under the laws
of the State of Montana on August 13, 1981 under the name Golden Maple Mining
and Leaching Company, Inc. On May 23, 1998, we changed our name to Consolidated
Medical Management, Inc. In August 2001, the Company decided to refocus on the
oil and gas industry and are currently doing business as Consolidated Minerals
Management, Inc. CMMI's address was 5161 San Felipe, Suite 320, Houston, Texas
77056 until July 2003 when the Company moved offices to 11919 Sunray Avenue,
Suite B, Baton Rouge, LA 70816.

RESULTS OF OPERATIONS

For the quarter ended June 30, 2005, CMMI incurred a net loss of $58,965 as
compared to a net loss of $ 78,338 for the quarter ended June 30, 2004. The loss
is attributable to the accrual of expenses incurred for consultants and
maintaining operations while seeking to restructure its business operations.


                                        9
<PAGE>
COMPARISON OF QUARTER ENDED JUNE 30, 2005 TO THE QUARTER ENDED JUNE 30, 2004

For the quarter ended June 30, 2005, our net loss was $58,965 as compared to
$78,338 for the quarter ended June 30, 2004. The loss is related to consulting
fees incurred from assistance developing a focused business plan and strategy
for obtaining the debt or equity financing that we will need to acquire energy
prospects.

LIQUIDITY AND CAPITAL RESOURCES

The Company's recurring negative financial results raise substantial doubt about
the Company's ability to continue as a going concern.

The Company will need to raise additional funds through additional debt or
equity financing. There can be no assurance that additional equity or debt
financing will be available when needed or on terms acceptable to the Company.

The market price of the Company's common stock has fluctuated significantly
since it began to be publicly traded in 1998 and may continue to be highly
volatile. Factors such as the ability of the Company to achieve development
goals, ability of the Company to profitably complete energy projects, the
ability of the Company to raise additional funds, general market conditions and
other factors affecting the Company's business that are beyond the Company's
control may cause significant fluctuations in the market price of the Company's
common stock. The market prices of the stock of many energy companies have
fluctuated substantially, often unrelated to the operating or research and
development performance of the specific companies. Such market fluctuations
could adversely affect the market price for the Company's common stock.


                                       10
<PAGE>
                                     PART II

Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are omitted.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None

ITEM 5. EXHIBITS AND REPORTS ON FORM 8-K

None

                                   SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange
Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on
its behalf by the undersigned, there unto duly authorized, in the City of  Baton
Rouge, LA, August 15, 2005.

CONSOLIDATED MEDICAL MANAGEMENT, INC.



          By:  /s/  Timothy G. Byrd, Sr.

               Timothy G. Byrd, Sr.
               Chief Executive Officer, Acting Chief Accounting Officer,
               And Director






                                       12